SALMASO, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 1.535
EU - Europa 279
AS - Asia 255
SA - Sud America 14
AF - Africa 7
Totale 2.090
Nazione #
US - Stati Uniti d'America 1.520
CN - Cina 137
VN - Vietnam 82
IT - Italia 77
DE - Germania 35
FI - Finlandia 32
SE - Svezia 31
IE - Irlanda 28
GB - Regno Unito 21
FR - Francia 18
IN - India 17
CA - Canada 15
BR - Brasile 13
GR - Grecia 13
UA - Ucraina 6
PK - Pakistan 5
TR - Turchia 5
CH - Svizzera 4
BG - Bulgaria 3
MA - Marocco 3
NL - Olanda 3
PH - Filippine 3
ZA - Sudafrica 3
IR - Iran 2
JP - Giappone 2
RO - Romania 2
RU - Federazione Russa 2
SI - Slovenia 2
CL - Cile 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ES - Italia 1
ID - Indonesia 1
TW - Taiwan 1
Totale 2.090
Città #
Fairfield 267
Woodbridge 164
Chandler 114
Ashburn 111
Seattle 104
Cambridge 103
Houston 101
Ann Arbor 83
Dong Ket 74
Wilmington 73
Beijing 35
Columbus 30
Dublin 28
Helsinki 26
San Diego 25
Des Moines 17
Medford 17
Princeton 17
Padova 16
Nanjing 14
Boardman 9
Milan 9
London 8
North York 8
Pune 8
Hebei 7
Cagliari 6
Chennai 6
Guangzhou 5
Jinan 5
Kharkiv 5
Ogden 5
Rome 5
Shanghai 5
São Paulo 5
Hanoi 4
Hounslow 4
Istanbul 4
Tianjin 4
Can Tho 3
Changsha 3
Falls Church 3
Jiaxing 3
Kunming 3
Lahore 3
New York 3
North Vancouver 3
Roxbury 3
Sofia 3
Taizhou 3
Turin 3
Zurich 3
Arcade 2
Bologna 2
Chiampo 2
Chicago 2
Islamabad 2
Khouribga 2
Los Angeles 2
Munich 2
Nanchang 2
Navi Mumbai 2
Norwalk 2
Philadelphia 2
Pretoria 2
Redmond 2
San Jose 2
Shenyang 2
Siena 2
Sunnyvale 2
Windsor 2
Zhengzhou 2
Andover 1
Ashikaga 1
Assiut 1
Bellevue 1
Benglen 1
Berlin 1
Bochum 1
Buffalo 1
Cartagena 1
Casablanca 1
Chengdu 1
Chiswick 1
Civitanova Marche 1
Columbia 1
Council Bluffs 1
Da Nang 1
Edinburgh 1
Frankfurt am Main 1
Haikou 1
Hefei 1
Henderson 1
Horia 1
Islington 1
Izmir 1
Kemanggisan 1
Kilburn 1
Las Vegas 1
Lawrenceville 1
Totale 1.638
Nome #
[1,2,4]Triazolo[1,5-c]pyrimidines as adenosine receptor antagonists: Modifications at the 8 position to reach selectivity towards A3 adenosine receptor subtype 279
Synthesis, structure-activity relationships and biological evaluation of 7-phenyl-pyrroloquinolinone 3-amide derivatives as potent antimitotic agents 151
Deciphering the Complexity of Ligand-Protein Recognition Pathways Using Supervised Molecular Dynamics (SuMD) Simulations 139
Exploring Protein-Peptide Recognition Pathways Using a Supervised Molecular Dynamics Approach 132
Exploring protein flexibility during docking to investigate ligand-target recognition 131
AquaMMapS: an alternative tool to monitor the role of water molecules during protein-ligand association 113
Coupling Supervised Molecular Dynamics (SuMD) with Entropy Estimations To Shine Light on the Stability of Multiple Binding Sites 111
Could Adenosine Recognize its Receptors with a Stoichiometry Other than 1 : 1? 108
DockBench as docking selector tool: the lesson learned from D3R Grand Challenge 2015 104
New Trends in Inspecting GPCR-ligand Recognition Process: the Contribution of the Molecular Modeling Section (MMS) at the University of Padova 101
Targeting Protein Kinase CK1δ with Riluzole: Could It Be One of the Possible Missing Bricks to Interpret Its Effect in the Treatment of ALS from a Molecular Point of View? 100
Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: An overview 92
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 84
Discovery of 2-aminoimidazole and 2-amino imidazolyl-thiazoles as non-xanthine human adenosine A 3 receptor antagonists: SAR and molecular modeling studies 76
Combining self- and cross-docking as benchmark tools: the performance of DockBench in the D3R Grand Challenge 2 76
Sulfonamido-derivatives of unsubstituted carbazoles as BACE1 inhibitors 75
Amphiphilic peptide-based MMP3 inhibitors for intra-articular treatment of knee OA 25
Direct Comparison of (N)-Methanocarba and Ribose-Containing 2-Arylalkynyladenosine Derivatives as A3Receptor Agonists 24
Supervised Molecular Dynamics (SuMD) Approaches in Drug Design 19
Survey of ribose ring pucker of signaling nucleosides and nucleotides 17
Design and in Vivo Characterization of A 1 Adenosine Receptor Agonists in the Native Ribose and Conformationally Constrained (N)-Methanocarba Series 17
In silico drug design for purinergic gpcrs: Overview on molecular dynamics applied to adenosine and p2y receptors 16
Exploration of Alternative Scaffolds for P2Y14Receptor Antagonists Containing a Biaryl Core 15
Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2Y14R Antagonist 15
A3 adenosine receptor agonists containing dopamine moieties for enhanced interspecies affinity 15
Purinergic Signaling: Impact of GPCR Structures on Rational Drug Design 15
Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human A3 Adenosine Receptors: Affinity Enhancement by N6-(2-Phenylethyl) Substitution 14
Fluorescent A2A and A3 adenosine receptor antagonists as flow cytometry probes 14
Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets 12
Structure-Activity Relationship of 3-Methylcytidine-5'-α,β-methylenediphosphates as CD73 Inhibitors 10
Purinergic GPCR transmembrane residues involved in ligand recognition and dimerization 8
Thermal Titration Molecular Dynamics (TTMD): Not Your Usual Post-Docking Refinement 7
Structure-Activity Studies of 1H-Imidazo[4,5-c]quinolin-4-amine Derivatives as A3 Adenosine Receptor Positive Allosteric Modulators 4
Structure-Activity Relationship of Heterocyclic P2Y14Receptor Antagonists: Removal of the Zwitterionic Character with Piperidine Bioisosteres 4
Synthesis and Effect of Conformationally Locked Carbocyclic Guanine Nucleotides on Dynamin 4
Selective A3 Adenosine Receptor Antagonist Radioligand for Human and Rodent Species 3
[1,2,4]Triazolo[1,5‐c]pyrimidines as Tools to Investigate A3 Adenosine Receptors in Cancer Cell Lines 3
Thermal titration molecular dynamics (TTMD): shedding light on the stability of RNA-small molecule complexes 2
2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A1 Adenosine Receptor Positive Allosteric Modulators 2
Stereocontrolled access to thioisosteres of nucleoside di- and triphosphates 1
Pyrazolo-triazolo-pyrimidine Scaffold as a Molecular Passepartout for the Pan-Recognition of Human Adenosine Receptors 1
First Potent Macrocyclic A3 Adenosine Receptor Agonists Reveal G-Protein and β-Arrestin2 Signaling Preferences 1
Totale 2.140
Categoria #
all - tutte 9.622
article - articoli 8.777
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 364
Totale 18.763


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019155 0 0 0 0 0 0 0 0 0 0 80 75
2019/2020407 42 47 2 29 45 43 34 47 61 21 23 13
2020/2021382 16 12 20 13 4 13 4 16 45 93 55 91
2021/2022315 11 37 31 20 34 11 13 51 17 10 20 60
2022/2023412 31 12 6 46 57 86 3 30 65 22 36 18
2023/2024310 50 36 56 21 42 20 33 28 13 11 0 0
Totale 2.140